ARROW: pralsetinib hits target across cancers
Crossref DOI link: https://doi.org/10.1038/s41571-022-00683-5
Published Online: 2022-08-23
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2022-08-23
Version of Record valid from 2022-08-23
Article History
First Online: 23 August 2022